Rajiv Gandhi Cancer Institute and Research Centre
India's premier non-profit cancer hospital delivering comprehensive oncological care across 20+ sub-specialties, with advanced capabilities in CAR-T cell therapy, bone marrow transplantation, precision oncology, and nuclear medicine for patients from across South Asia and beyond.
About Rajiv Gandhi Cancer Institute and Research Centre
Rajiv Gandhi Cancer Institute and Research Centre (RGCIRC) is a non-profit, dedicated cancer hospital and research institute located in Rohini, New Delhi, India. Founded on 1 July 1996 as a project of the Indraprastha Cancer Society and Research Centre, it is one of the largest medical centres for cancer treatment in Asia, treating over 60,000 patients annually from India, Nepal, Bangladesh, Sri Lanka and other countries across South Asia, the Middle East and Africa.
The hospital's main campus in Rohini houses over 500 beds, 57 consultation rooms across three floors, 14 state-of-the-art modular operation theatres with three-stage air filtration, a 51-bed Surgical ICU, 21-bed Medical ICU, dedicated Bone Marrow Transplant unit, Leukemia ward, Thyroid ward, and stem cell transplant facilities. A second campus at Niti Bagh in South Delhi, opened in 2016, extends access to cancer services in the city's southern region. RGCIRC holds NABH accreditation, NABL certification, ISO 9001 and ISO 14001 certifications, and is a member of the Union for International Cancer Control (UICC).
RGCIRC offers comprehensive cancer management across more than 20 oncology sub-specialties, supported by over 100 consultant oncologists, 150 resident doctors, and 650 support staff. The institute is recognised for its work in CAR-T cell therapy, haematopoietic stem cell transplantation, surgical oncology, radiation oncology, nuclear medicine, and precision diagnostics. Academic partnerships include a collaboration with Thomas Jefferson University, and the institute conducts DNB programmes, IMA fellowship courses, and IAEA-sponsored training in oncological radiology.
CancerFax works directly with RGCIRC's International Patients Division to help patients worldwide access its specialist oncology programmes. From submitting medical records and securing a clinical review to coordinating visa support and pre-arrival logistics, CancerFax manages the entire process at no cost to the patient, ensuring that those who need RGCIRC's expertise can access it without barriers.
| Hospital at a Glance | |
|---|---|
| Country | India |
| City | New Delhi (Rohini & Niti Bagh campuses) |
| Established | 1 July 1996 |
| Hospital Type | Non-Profit Dedicated Cancer Hospital & Research Centre |
| Accreditation | NABH · NABL · ISO 9001 · ISO 14001 · UICC Member · NABH Digital Health (2024) |
| Beds | 500+ (Rohini), 30 (Niti Bagh) |
| Annual Cancer Patients | 60,000+ |
| Research Focus | CAR-T cell therapy, HSCT, surgical oncology, radiation oncology, nuclear medicine, precision diagnostics, NanoKnife IRE |
Why Patients Choose RGCIRC
RGCIRC is one of Asia's most experienced dedicated cancer centres, combining comprehensive multi-specialty oncology with cutting-edge research, advanced surgical infrastructure, and a deeply rooted culture of compassionate, patient-first care.
Cancer Specialties and Clinical Departments
RGCIRC offers comprehensive cancer care across more than 20 oncology sub-specialties, with disease-specific multidisciplinary tumour boards ensuring that every complex case receives collaborative, evidence-based treatment planning.
Advanced Treatment Capabilities
Senior Oncology Team at RGCIRC
RGCIRC's clinical leadership includes internationally trained oncology specialists with decades of experience across all major cancer types. Dr. Sudhir Rawal serves as Chairman and Chief of Uro-Oncology and Robotic Surgery, a pioneer of robotic uro-oncological surgery in India with over three decades of experience. Dr. Gauri Kapoor, Director of Pediatric Hematology Oncology, is a renowned paediatric oncologist with over 25 years specialising in childhood leukaemia, solid tumours, and stem cell transplantation in children. Dr. Dinesh Bhurani, Director of Hemato-Oncology and Bone Marrow Transplant, leads RGCIRC's CAR-T cell therapy programme and is one of India's most experienced BMT specialists.
Dr. Archana Atreja (Director, Surgical Oncology — Head and Neck) specialises in complex head and neck surgical oncology with expertise in reconstructive surgery. Dr. Vipul Sheth (Senior Consultant, BMT and Cell Therapy) leads the bone marrow transplant and cell therapy unit with expertise in autologous and allogeneic transplants. CancerFax matches patients with the most appropriate RGCIRC specialist for their specific cancer type and coordinates consultations before any travel commitment.
⚠ VERIFY: Full team list and exact titles should be confirmed against the current RGCIRC website. CancerFax can connect patients with the most appropriate specialist for their specific cancer type.
Clinical and Research Infrastructure
RGCIRC's 10-storey main campus in Rohini is purpose-built for comprehensive cancer management, combining advanced diagnostics, surgical theatres, radiation facilities, and research labs in a single integrated facility.
- 14 modular operation theatres with three-stage laminar air flow, robotic surgery capability, NanoKnife IRE, and intraoperative radiation therapy (IORT)
- 51-bed Surgical ICU for post-operative and complex cancer surgery support
- Multiple linear accelerators providing IMRT, IGRT, SRS/SRT, and brachytherapy (HDR and LDR)
- Advanced treatment planning with real-time image guidance
- Dedicated HEPA-filtered BMT unit for autologous and allogeneic transplants including MUD and haploidentical transplants, with on-site cell processing laboratory
- Active CAR-T cell therapy programme for relapsed/refractory haematologic malignancies
- PET-CT, 3T MRI, CT simulation, digital mammography, molecular diagnostics lab with NGS, FISH, flow cytometry, and comprehensive histopathology
- Nuclear medicine: radioiodine therapy for thyroid cancer, MIBG therapy, bone scans and PET-CT
International Patient Support at RGCIRC
RGCIRC actively serves international cancer patients from across South Asia, the Middle East, and Africa, with a dedicated International Patients Division and lounge facility at the Rohini campus.
What to Prepare Before Traveling
- arrow_rightShare complete pathology reports, recent CT/PET-CT/MRI imaging, prior treatment summaries, biopsy slides where available, molecular profiling results, and a current medication list (in English) with CancerFax at least one to two weeks before your planned RGCIRC consultation.
- arrow_rightApply for an Indian medical visa (M visa) at the Indian high commission or consulate in your country. RGCIRC can issue an official invitation letter for the patient and accompanying family members.
- arrow_rightPlan travel via Indira Gandhi International Airport (DEL), approximately 25-30 km from the Rohini campus (45-75 minutes by taxi depending on traffic). RGCIRC can also be reached by Delhi Metro (Red Line, Rithala station) with a short auto-rickshaw connection.
⚠ VERIFY: Exact interpreter and language services available at RGCIRC. CancerFax provides additional accredited translation and coordination support for patients from non-English-speaking regions, particularly South Asian, MENA, and African patients.
Patient Facilities and Amenities at RGCIRC
RGCIRC provides comprehensive patient and family support services across its Rohini main campus, including general, semi-private, private, and VIP inpatient accommodation options with 24/7 emergency services.
Family members accompanying international patients to RGCIRC can access guest house and hotel coordination arranged through the International Patients Division. The Rohini area in North-West Delhi offers accommodation at various price points. CancerFax assists with extended-stay accommodation planning for families during chemotherapy cycles, radiation therapy, or bone marrow transplant programmes.
How to Reach RGCIRC
RGCIRC's main campus is located in Sector 5, Rohini, North-West Delhi, well connected by the Delhi Metro Red Line (Rithala station) and major arterial roads. A second campus in Niti Bagh serves South Delhi.
How CancerFax Helps
CancerFax is a specialist cancer access and patient-navigation platform. We help patients and families understand their options, organise medical records, coordinate hospital communication, and support cross-border treatment planning where appropriate.
We help collect and organise reports, scans, pathology, biomarker results, and treatment history for structured case review.
We communicate with hospitals or trial teams to assess whether a case may be suitable for further screening.
We support appointment coordination, document submission, translation, and direct communication with international departments.
For international patients, we help with practical coordination — travel planning, hospital admission guidance, and local support.
If this option is not suitable, we help explore other relevant treatments, clinical trials, or advanced care pathways.
From inquiry through to follow-up, our coordinators provide a single point of contact for the family.
CancerFax does not guarantee treatment access, eligibility, or clinical outcome. Our role is to help patients access accurate information, structured review, and appropriate specialist pathways.
RGCIRC — Patient Questions Answered
RGCIRC treats all types of cancer across 20+ sub-specialties including blood cancers (leukaemia, lymphoma, myeloma), breast, lung, head and neck, gastrointestinal, urological, gynaecological, brain, paediatric cancers, and rare cancers. Multidisciplinary tumour boards review complex cases to determine optimal treatment strategies. CancerFax can confirm whether RGCIRC is the right fit for your specific cancer type and stage before any travel commitment.
Yes. RGCIRC has an active CAR-T cell therapy programme for relapsed and refractory haematologic malignancies, led by the Hemato-Oncology and Bone Marrow Transplant department under Dr. Dinesh Bhurani. CancerFax can help assess whether you are a candidate and facilitate the referral process, including parallel evaluation at other Indian CAR-T centres if relevant.
International patients can contact RGCIRC's International Patients Division directly or work with CancerFax for end-to-end coordination. CancerFax handles medical record review, specialist matching, visa invitation letters, appointment scheduling, accredited report translation, and travel logistics at no cost to the patient. The process typically begins with submitting your medical records for a preliminary review before any travel commitment.
RGCIRC is NABH accredited, NABL certified, holds ISO 9001 and ISO 14001 certifications, received NABH Digital Health certification in 2024, and is a member of the Union for International Cancer Control (UICC). Academic collaborations include Thomas Jefferson University in the United States. The institute conducts DNB programmes, IMA fellowship courses, and IAEA-sponsored training in oncological radiology.
Yes. RGCIRC performs both autologous and allogeneic bone marrow transplants including matched related donor, matched unrelated donor (MUD), and haploidentical transplants. The BMT unit has a dedicated HEPA-filtered ward, 21-bed Medical ICU, and on-site cell processing laboratory. The programme is led by Dr. Dinesh Bhurani, one of India's most experienced BMT specialists.
Send Your Medical Reports to RGCIRC via CancerFax
CancerFax reviews your records, identifies whether RGCIRC, another Indian cancer centre, or an international option is the right clinical fit, and coordinates your consultation or remote second opinion in Delhi at no cost, with no obligation, and with full medical confidentiality throughout.